Effect of a hot environment on performance, carcass characteristics, and blood hormones and metabolites of pigs treated with porcine somatotropin.
A study was conducted to compare the effects of a single 100-mg recombinant porcine somatotropin (rpST) implant on performance, carcass characteristics, and blood hormones and metabolites of 40 finishing pigs exposed to either a thermoneutral (TN; 18 to 21 degrees C) or hot environment (H; 27 to 35 degrees C) for 28 or 35 d. Pigs in H gained at a slower rate (P less than .01) than pigs in TN. Control and rpST-treated pigs gained at similar rates in respective environments. The rpST-treated pigs consumed 13% less feed (P less than .01) than the control pigs in both environments, and pigs in H consumed 19% less feed (P less than .01) than pigs in TN. Feed efficiency for rpST-treated pigs was 15% better (P less than .01) than that for control pigs; environment had no effect on feed efficiency. When slaughtered, pigs treated with rpST had less (P less than .01) leaf fat and less (P less than .01) 10th rib backfat than control pigs. Pigs in H had a lower (P less than .01) final BW and less leaf fat and backfat than pigs in TN. The rpST and H had various effects on blood hormones and metabolites. The results demonstrated that the benefits of this form of rpST treatment achieved under TN were also achieved in H with no interactions between the hormone and environment.
Becker
B A
BA
Animal Physiology Unit, ARS, USDA, Columbia, MO 65211.
Knight
C D
CD
Buonomo
F C
FC
Jesse
G W
GW
Hedrick
H B
HB
Baile
C A
CA
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001806:Blood Urea Nitrogen; D001831:Body Temperature; D004343:Drug Implants; D004435:Eating; D005260:Female; D013006:Growth Hormone / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D006358:Hot Temperature; D006813:Humidity; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D007335:Insulin-Like Growth Factor II / Q000032:analysis; D008297:Male; D008460:Meat / Q000592:standards; D011897:Random Allocation; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology; D012119:Respiration; D012709:Serum Albumin / Q000032:analysis; D013552:Swine / Q000097:blood / Q000254:growth & development / Q000502:physiology*; D014284:Triiodothyronine / Q000097:blood; D015430:Weight Gain
D001786:Blood Glucose; D004343:Drug Implants; D011994:Recombinant Proteins; D012709:Serum Albumin; D014284:Triiodothyronine; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; D013006:Growth Hormone